Effect of Sedative and Anxiolytic Premedication on Children Experience After General Anesthesia
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Midazolam, Dexmedetomidine, Placebo.
- Who it may be relevant to
- Registry conditions: Anesthesia. Basic parameters: 7 years — 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- France
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
" Effect of Sedative and Anxiolytic Premedication on Children Experience After General Anesthesia " The pediaPREM Study.
Overview
Children undergoing general anesthesia for surgery commonly need sedative and anxiolytic premedication but little clinical evidence supports is benefit for children older than 7 years old. The aim of this prospective randomized clinical trial is to assess the impact of pharmacologic premedication on perioperative children experience.
Detailed description
Surgery is a stressful experience in children with preoperative and postoperative anxiety.
For preschooler undergoing surgery, anxiety is the highest in the preoperative period.
Most of studies have been conducted on young children (\< 7yrs old) to show the relationship between preoperative anxiety and emergence of delirium and postoperative maladaptive behavioral changes.
Sedative and anxiolytic medication is frequently used in children to reduce anxiety and postoperative maladaptive experiences. Nevertheless, little clinical evidence supports is benefit for children older than 7 years.
Treating anxiety is not necessarily associated with better experience in all children because premedication causes postoperative sedation, amnesia and cognitive impairment.
The aim of this prospective randomized clinical trial is to assess the impact of pharmacologic premedication on perioperative children experience using self-report questionnaire.
Patients are randomized to 2 groups to received pharmacologic premedication or placebo.
For the premedication group, children are randomly allocated to be premedicated with either with the midazolam or dexmedetomidine
Interventions
- Drug Midazolam
45 minutes before entering the operating room, patient receives the oral treatment according to their randomization arm, here Midazolam , by a blinded nurse. - Drug Dexmedetomidine
45 minutes before entering the operating room, patient receives the oral treatment according to their randomization arm, here Dexmedetomidine , by a blinded nurse. - Drug Placebo
45 minutes before entering the operating room, patient receives the oral treatment according to their randomization arm, here Grenadine Syrup, by a blinded nurse.
Primary outcome measures
- EVANpedia Score [Time frame: from the day of surgery up to the day one after surgery]
Secondary outcome measures (8)
- VAS-anxiety Scores [Time frame: from preoperative period up to 6 postoperative month]
- Postoperative waking delay [Time frame: from the end of the surgery up to the exit of the recovery room]
- Modified Brice questionnaire Score [Time frame: from the day of surgery up to 1 day]
- Post Hospitalization Behavior Scores [Time frame: 15 postoperative days]
- quality of life [Time frame: 6 postoperative months]
- neuropathic pain [Time frame: 6 postoperative month]
- FPS-r scores [Time frame: from the end of the surgery up to 6 post-operative month]
- Quality of life PedsQL [Time frame: Up to 6 months post-operatively]
Eligibility criteria
Inclusion criteria
- Subject over 7 and under 18 years of age
- Subjects who are scheduled for surgery
- Subject who will be under general anesthesia
- Subject able to complete a self-questionnaire in French
Exclusion criteria
- Subject who has already participated in the pediaPREM study
- Subject with a treated anxiety disorder
- Subject with cognitive disorders
- Subject suffering from chronic pain (outside the operated area)
- Subject with ADD (Attention Deficit Disorder) with or without hyperactivity, with or without treatment
- Subject suffering from mental retardation
- Subjects receiving psychotropic treatment
- Subject whose intervention could reduce the ability to complete a self-questionnaire (neurosurgery etc.)
- Subject with a contra-indication to midazolam and its excipients
- Subject with a contra-indication to dexmedetomidine and its excipients
- Subjects who need to receive intravenous alpha agonist in perioperative
- Subjects requiring emergency intervention
- Subjects requiring preoperative hypnosis
- Subject who needs general anesthesia for diagnostic purposes (biopsy, etc...)
- Subject having had a surgical intervention in the month preceding the inclusion.
- Subject who will have an iterative surgical intervention within 15 days (removal of material, burns etc...)
- Subjects who are scheduled for surgery as part of oncology management
- Pregnant or breastfeeding woman
- Subject whose two parents have not signed a written informed consent
- Subjects who are not affiliated with or benefiting from a social security plan
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Double blind
- Primary purpose
- Treatment
Study locations
France · 1 center
- Uhmontpellier — Montpellier
Identifiers
NCT: NCT05681572 · RECHMPL21_0354 · 2022-501124-23-00